The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Smith Karen L. since year 2005.
The trader's CIK number is 1639637.
At the time of this reporting, Smith Karen L. is the Global Head of R&D and CMO of Jazz Pharmaceuticals Inc .
(stock ticker symbol JAZZ).
See this page for all insider trading activities at Jazz Pharmaceuticals Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2016-08-12||JAZZ||Jazz Pharmaceuticals Inc||Buy||608||137.18||83,406|
|2016-07-13||JAZZ||Jazz Pharmaceuticals Inc||Buy||580||143.63||83,304|
|2016-06-13||JAZZ||Jazz Pharmaceuticals Inc||Buy||557||149.61||83,334|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Smith Karen L. (Global Head of R&D and CMO of Jazz Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.